Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer
Clinical trial NCT05965141 · UNKNOWN
Trial details
- NCT number
- NCT05965141
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-04-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.